InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 13.92
-0.34 (-2.38%)
Oct 22, 2025, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 28.3 billion as of October 22, 2025. Its market cap has increased by 125.75% in one year.
Market Cap
28.30B
Enterprise Value
22.27B
Revenue
1.45B
Ranking
n/a
PE Ratio
n/a
Stock Price
13.92
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 28.30B, an increase of 130.50%. That is a compound annual growth rate of 16.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 28.30B | 124.02% |
| Dec 31, 2024 | 12.63B | -7.63% |
| Dec 29, 2023 | 13.68B | -44.57% |
| Dec 30, 2022 | 24.68B | 7.55% |
| Dec 31, 2021 | 22.95B | 32.04% |
| Dec 31, 2020 | 17.38B | 41.53% |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 272.46B |
| Hansoh Pharmaceutical Group Company | 217.34B |
| JD Health International | 205.69B |
| Innovent Biologics | 148.84B |
| WuXi Biologics | 146.41B |
| Sino Biopharmaceutical | 132.29B |
| Akeso | 110.08B |
| Sichuan Kelun-Biotech Biopharmaceutical | 109.83B |